On Demand Grand Rounds: Preventing Alzheimer's: Pipedream or Possibility?

CZARINA SANTOS-BORJA, MD MEMORIAL LECTURE

This presentation was originally reviewed on April 19, 2022, and broadcast live online on April 20, 2022, from 12:00 PM – 1:00 PM ET. 

The views and opinions expressed by this presenter in this lecture are their own, and do not represent the views of Sheppard Pratt.

Most clinicians are surprised to learn that the scientific advances in the Alzheimer’s field have led to the identification of multiple novel targets for treatment and even prevention of the disease. Multiple prevention studies have been launched in the last several years, with readouts pending from several. It remains to be seen whether/when these will be relevant for practice, but this could happen as early as 2023. In parallel, there have been dramatic advances in the development of imaging, and especially blood, biomarkers that have already transformed how treatment and prevention research are conducted and are poised to transform how we diagnose and monitor brain diseases in practice.

Target Audience

This activity is intended for physicians, nurses, psychologists, social workers, counselors and other mental health professionals. 

Learning Objectives

At the conclusion of this activity, attendees will be able to:

  1. Estimate the number of Alzheimer’s prevention trials launched in the last decade.
  2. Describe the key enrichment techniques that are used in Alzheimer's prevention trials
  3. Explain examples of classes or types of interventions that have been used in recent Alzheimer’s prevention trials.
Course summary
Available credit: 
  • 1.00 ACEP NBCC clock hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Category II credits for Social Workers
  • 1.00 Psychologists
  • 1.00 MNA Contact Hours for Nurses
  • 1.00 Participation
Course opens: 
01/03/2024
Course expires: 
12/31/2025

Sheppard Pratt is dedicated to improving quality of life through mental health, special education, and addiction services for children, adolescents, adults and older adults.  Our patient-centered treatment approach, combined with our legacy of clinical excellence, sets us apart from other health systems on both a local and national level.  We have been ranked among the nation’s top psychiatric hospitals for 24 consecutive years by U. S. News & World Report.  Founded in 1853 by philanthropist Moses Sheppard, Sheppard Pratt Health System still abides by its Quaker traditions and values.

Sheppard Pratt regularly hosts renowned speakers from across the country at our headquarters in Towson. We provide educational opportunities on subjects including psychiatric disorders, issues of behavioral health, systems-based change, mental and somatic co-morbidities, psychiatric effects on health and health outcomes, advances in neurobiology, and clinical developments in concepts underlying drug treatment of psychiatric disorders. We are accredited by the Accreditation Council of Continuing Medical Education, the Maryland Nurses’ Association, the Maryland Board of Psychology, the Maryland Board of Social Work, and the National Board of Certified Counselors.

Sheppard Pratt’s Professional Education Program is pleased to provide Wednesdays at Sheppard Pratt free of charge as a public service to the mental health community.  Your tax-deductible donations will help maintain the outstanding quality of this service. 

Please send your contributions to:

Sheppard Pratt Professional Education Program
Wednesdays Lecture Fund
6501 North Charles Street, Baltimore, Maryland 21204

Professional Education Program: 410.938.4593
Conference Center at Sheppard Pratt: 410.938.3900

There is no commercial support for this activity.

About the speaker

Dr. Tariot is Board Certified in Internal Medicine and Psychiatry with added qualifications in geriatrics.  He was a Fellow at the National Institute of Mental Health (NIMH) Intramural Research Program, then served as a faculty member at the University of Rochester Medical Center and, since 2006, he has served as Director of the Banner Alzheimer’s Institute in Phoenix. He is also a Research Professor of Psychiatry at the University of Arizona College of Medicine. His work has focused on care and study of people with and at risk for Alzheimer’s, with special emphasis on design and implementation of clinical trials for prevention and treatment, development of biomarkers, measurement, and treatment of neuropsychiatric features of dementia and demonstration of effective dementia care. His experience includes conceiving, funding, and implementing single center and multicenter trials, and serving as Principal Investigator on over 50 clinical trials related to Alzheimer’s and related dementias. He has published over 400 papers on these topics including those regarding studies that have led to FDA approval of new medications. He serves as co-director of the international Alzheimer’s Prevention Initiative (API). His research affiliations include the National Institute on Aging (NIA), the NIMH, and the Alzheimer’s Association and he is a Fellow of the American College of Neuropsychopharmacology.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Pierre N. Tariot, MDreports having the following relationships with commercial interests: Abbvie-Consultant-Honoraria; AC Immune-Consultant-Honoraria; Acadia-Consultant-Honoraria; Clinical Care Options-Consultant-Honoraria; CME Outfitters-Speaker-Honoraria; Cortexyme-Consultant-Honoraria; Eisai-Consultant-Honoraria, MedEdicus-Speaker-Honoraria; Merck-Consultant. He will be discussing experimental treatments for Alzheimer’s. All relationships have been mitigated. This presentation will focus on research. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, Lisa Illum MLIS, MEd,  and Jennifer Tornabene.

Physician Statement: Sheppard Pratt is accredited by The Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity.  Sheppard Pratt designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Statement: Sheppard Pratt is an approved provider of continuing nursing education by Maryland Nurses Association. The Maryland Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity provides 1.0 contact hours for nurses.

Psychologist Statement: Sheppard Pratt is authorized by the State Board of Examiners of Psychologists as a sponsor of continuing education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CE activity.  Sheppard Pratt designates this educational activity for a maximum of 1.0 contact hours for Psychologists.

Social Worker Statement: Sheppard Pratt is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers.  Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CE activity. This activity is approved for 1.0 contact hours in Category II credits for Social Workers.

Counselor Statement:  Sheppard Pratt has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5098.  Programs that do not qualify for NBCC credit are clearly identified.  Sheppard Pratt is solely responsible for all aspects of the program.  This activity is available for 1.0 NBCC clock hours.

Available Credit

  • 1.00 ACEP NBCC clock hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Category II credits for Social Workers
  • 1.00 Psychologists
  • 1.00 MNA Contact Hours for Nurses
  • 1.00 Participation
Please login or register to take this course.

ON DEMAND WEBINAR: FOR BEST RESULTS WATCH USING GOOGLE CHROME

Grand Rounds: Preventing Alzheimer's: Pipedream or Possibility?

Pierre N. Tariot, MD

Director, Banner Alzheimer’s Institute

Research Professor of Psychiatry, University of Arizona College of Medicine

Phoenix, Az

Originally reviewed April 19, 2022.
Originally broadcast live April 20, 2022, from 12:00 PM – 1:00 PM ET
Enduring Activity Credit Expiration Date: December 31, 2026.

Activity Time: One hour webinar lecture with a 15-minute evaluation process. Total Time: 1:45.

TO EARN CONTINUING EDUCATION CREDIT FOR YOUR ATTENDANCE
On the OVERVIEW or REGISTER/TAKE COURSE tab, select the GREEN RECTANGLE, TAKE COURSE to begin.
Complete the Pretest and select NEXT in the bottom right corner of the screen. Use the NEXT button for best results.
The PowerPoint handout will be available for download.
After downloading the handout, select NEXT to begin and watch the video. 
You may need to select play for the video to begin.
After the video follow the prompts to complete the posttest, evaluation and attestation of credit. 
Once you have completed all the components of the Course Progress bar, the certificate will be immediately downloadable.

FINANCIAL SUPPORT
There is no commercial support for this activity.

Questions? Look at our FAQ’s at https://cme.sheppardpratt.org/content/faq or Email cme@sheppardpratt.org

Required Hardware/software

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.